Faculty and staff of the HICCC answer the call to volunteer at the Armory--a major COVID-19 vaccination site at NYP and CUIMC. They share what motivated them to get involved!
Drs. Sankar Ghosh, Brent Stockwell, and Zhiguo Zhang are recipients of the translational research awards by the new partnership, Columbia-Sumitomo Dainippon Pharma Oncology Alliance.
HICCC signs open letter, with more than 75 other leading cancer organizations, that urges patients to resume their cancer treatment and schedule their cancer screenings during the COVID-19 pandemic.
Researchers at the HICCC and Columbia University Vagelos College of Physicians and Surgeons are piloting a text messaging platform to remind individuals about HPV vaccine appointments.
Low- and middle-income countries are bearing the brunt of the global burden of cancer. To address this health gap, the HICCC has partnered with ICAP, ato launch the ICAP-HICCC Cancer Initiative.
A new analysis led by Andrea Califano, Dr, and Cory Abate-Shen, PhD, found that regardless of the cancer’s origin, tumors could be stratified in only 112 subtypes.
A study, led by HICCC members, has found that up to 20% of glioblastomas—an aggressive brain cancer—are fueled by overactive mitochondria and may be treatable with drugs currently in clinical trials.
In December 2020, the United States FDA authorized two approved COVID-19 vaccines. HICCC Deputy Director Gary Schwartz, MD, addresses what patients with cancer should know about the new vaccines.
